113 related articles for article (PubMed ID: 17976770)
1. Idiopathic cardiac electrical storm.
Davis JE; Curtis LA; Rashid H
J Emerg Med; 2009 Oct; 37(3):264-8. PubMed ID: 17976770
[TBL] [Abstract][Full Text] [Related]
2. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
Fuchs T; Groysman R; Meilichov I
Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
[TBL] [Abstract][Full Text] [Related]
3. An overview of antiarrhythmic drug management of electrical storm.
Kowey PR
Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
[TBL] [Abstract][Full Text] [Related]
4. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
[TBL] [Abstract][Full Text] [Related]
5. Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone.
Tsagalou EP; Kanakakis J; Rokas S; Anastasiou-Nana MI
Int J Cardiol; 2005 Mar; 99(2):341-2. PubMed ID: 15749200
[TBL] [Abstract][Full Text] [Related]
6. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
Alboni P
Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
[TBL] [Abstract][Full Text] [Related]
7. An overview of the management of electrical storm.
Dorian P; Cass D
Can J Cardiol; 1997 Mar; 13 Suppl A():13A-17A. PubMed ID: 9117921
[TBL] [Abstract][Full Text] [Related]
8. Electrical storm: clinical manifestations and management.
Littmann L; Rennyson SL
Minerva Med; 2007 Oct; 98(5):489-501. PubMed ID: 18043559
[TBL] [Abstract][Full Text] [Related]
9. Electrical storm: case series and review of management.
Srivatsa UN; Ebrahimi R; El-Bialy A; Wachsner RY
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):237-46. PubMed ID: 14506549
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone is poorly effective for the acute termination of ventricular tachycardia.
Marill KA; deSouza IS; Nishijima DK; Stair TO; Setnik GS; Ruskin JN
Ann Emerg Med; 2006 Mar; 47(3):217-24. PubMed ID: 16492484
[TBL] [Abstract][Full Text] [Related]
11. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
Ohnishi S; Kasanuki H
J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
[TBL] [Abstract][Full Text] [Related]
12. [Radiofrequency ablation as acute treatment of ventricular arrhythmia].
Emerek K; Riahi S; Hjortshøj SP
Ugeskr Laeger; 2013 Jan; 175(1-2):48-51. PubMed ID: 23305641
[TBL] [Abstract][Full Text] [Related]
13. [Etiologies of electric storm].
Dorian P
Arch Mal Coeur Vaiss; 1997 Apr; 90 Spec No 1():27-31. PubMed ID: 9238454
[TBL] [Abstract][Full Text] [Related]
14. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade.
Kantharia BK; Patel JA; Nagra BS; Ledley GS
Europace; 2006 Aug; 8(8):625-8. PubMed ID: 16772367
[TBL] [Abstract][Full Text] [Related]
15. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
[TBL] [Abstract][Full Text] [Related]
16. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.
Carbucicchio C; Santamaria M; Trevisi N; Maccabelli G; Giraldi F; Fassini G; Riva S; Moltrasio M; Cireddu M; Veglia F; Della Bella P
Circulation; 2008 Jan; 117(4):462-9. PubMed ID: 18172038
[TBL] [Abstract][Full Text] [Related]
17. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
18. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
[TBL] [Abstract][Full Text] [Related]
19. [Eleven-years long follow-up in a patient after myocardial infarction, with low ejection fraction and recurrent ventricular tachycardia. The role of implantable cardioverter defibrillator and selective ablation].
Przybylski A; Derejko P; Iwanek M; Urbanek P; Kepski R; Grzybowski J; Chojnowska L; Szumowski Ł; Szwed H; Walczak F
Kardiol Pol; 2006 Jul; 64(7):758-62. PubMed ID: 16886137
[TBL] [Abstract][Full Text] [Related]
20. [Electrical storm in patients with implantable cardioverter-defibrillator].
Bárzaga FJ; Clavijo PC; Sánchez MD; Hevia JC; Molina RZ; Pérez MA; Leza JB; Rodríguez YF; Balea FD
Arch Cardiol Mex; 2008; 78(1):68-78. PubMed ID: 18581715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
